These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9758345)

  • 21. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
    Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
    Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recto-colonic and hepatic involvement in graft-vs-host disease after bone marrow transplantation].
    Cessot F; Sautereau D; Devalois B; Dupuy JF; Le Sidaner A; Florence J; Catanzano G; Pillegand B
    Ann Gastroenterol Hepatol (Paris); 1991; 27(1):21-5. PubMed ID: 2029181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Liver dysfunction in recipients of hematopoietic stem cells. Impact on mortality].
    Cocozzella D; Méndez C; Malacalza J; Adrover R; Borzi S; Saba S; Canepa C; Fraquelli E; Curciarello J
    Medicina (B Aires); 2005; 65(2):113-6. PubMed ID: 16075803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatitis post-bone marrow transplantation.
    Shore T; Bow E; Greenberg H; Persad R; Patterson D; Rubinger M; Schroeder ML
    Bone Marrow Transplant; 1996 Jun; 17(6):1181-4. PubMed ID: 8807134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease.
    Nishida T; Hamaguchi M; Hirabayashi N; Haneda M; Terakura S; Atsuta Y; Imagama S; Kanie T; Murata M; Taji H; Suzuki R; Morishita Y; Kodera Y
    Bone Marrow Transplant; 2004 Jun; 33(11):1143-50. PubMed ID: 15077133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients.
    Tomás JF; Pinilla I; García-Buey ML; García A; Figuera A; Gómez-García de Soria VGG ; Moreno R; Fernández-Rañada JM
    Bone Marrow Transplant; 2000 Sep; 26(6):649-55. PubMed ID: 11035372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.
    Ferrà C; de Sanjosé S; Gallardo D; Berlanga JJ; Rueda F; Marìn D; de la Banda E; Ancìn I; Peris J; Garcìa J; Grañena A
    Haematologica; 1998 Dec; 83(12):1082-7. PubMed ID: 9949625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful renal transplantation following prior bone marrow transplantation in pediatric patients.
    Thomas SE; Hutchinson RJ; DebRoy M; Magee JC
    Pediatr Transplant; 2004 Oct; 8(5):507-12. PubMed ID: 15367289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colour doppler sonography guided percutaneous fine-needle biopsy of the liver.
    Polaków J; Ladny JR; Dziecioł J; Puchalski Z; Walecki J
    Rocz Akad Med Bialymst; 1997; 42(1):241-4. PubMed ID: 9581487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corneal grafting and aggressive medication for corneal defects in graft-versus-host disease following bone marrow transplantation.
    Tarnawska D; Wylegała E
    Eye (Lond); 2007 Dec; 21(12):1493-500. PubMed ID: 17057649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute graft-versus-host disease of the heart.
    Roberts SS; Leeborg N; Loriaux M; Johnson FL; Huang ML; Stenzel P; Thiede C; Godder KT
    Pediatr Blood Cancer; 2006 Oct; 47(5):624-8. PubMed ID: 16206193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells.
    Ji S; Chen H; Wang H; Ma J; Pan S; Xue M; Zhu L; Liu J; Xiao M; Zhou L
    Chin Med J (Engl); 2001 Feb; 114(2):191-5. PubMed ID: 11780205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver.
    Duarte RF; Delgado J; Shaw BE; Wrench DJ; Ethell M; Patch D; Dhillon AP; Mackinnon S; Potter MN; Quaglia AF
    Biol Blood Marrow Transplant; 2005 Oct; 11(10):805-13. PubMed ID: 16182181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the Risk of Hemorrhagic Complication following Transjugular Liver Biopsy in Bone Marrow Transplantation Recipients.
    Ahmed O; Ward TJ; Lungren MP; Abdelrazek Mohammed MA; Hofmann LV; Sze DY; Kothary N
    J Vasc Interv Radiol; 2016 Apr; 27(4):551-7. PubMed ID: 26948328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germ cell damage and Leydig cell insufficiency in recipients of nonmyeloablative transplantation for haematological malignancies.
    Kyriacou C; Kottaridis PD; Eliahoo J; McKeag N; Bomford J; McGarrigle HH; Linch DC; Mackinnon S; Chatterjee R
    Bone Marrow Transplant; 2003 Jan; 31(1):45-50. PubMed ID: 12621506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Liver changes in bone marrow transplantation].
    Bruguera M; Carreras E; Cervantes F
    Med Clin (Barc); 1991 Apr; 96(13):510-4. PubMed ID: 1646915
    [No Abstract]   [Full Text] [Related]  

  • 37. [Ultrasound-guided percutaneous plugged biopsy of the liver in patients with coagulation disorders. Preliminary report].
    Méndez Gutiérrez TH; Dehesa Violante M; Rodríguez Jerkov J; de la Garza S; González Loya F
    Rev Gastroenterol Mex; 1990; 55(1):13-5. PubMed ID: 2291061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normal-looking skin in oncohaematological patients after allogenic bone marrow transplantation is not normal.
    Vassallo C; Brazzelli V; Alessandrino PE; Varettoni M; Ardigò M; Lazzarino M; Borroni G
    Br J Dermatol; 2004 Sep; 151(3):579-86. PubMed ID: 15377343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
    Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
    Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.